Diferencia entre revisiones de «Harbor:Creatinine screening prior to IV contrast»
(Text replacement - "Cr " to "creatinine ") |
Sin resumen de edición |
||
| Línea 10: | Línea 10: | ||
**Age >60 | **Age >60 | ||
**History of kidney disease | **History of kidney disease | ||
***Kidney transplant | ***[[Kidney transplant]] | ||
***Dialysis | ***[[Dialysis]] | ||
***Single kidney | ***Single kidney | ||
***Renal cancer | ***Renal cancer | ||
***Kidney surgery | ***Kidney surgery | ||
**Family history of kidney failure | **Family history of kidney failure | ||
**Diabetes | **[[Diabetes]] | ||
**Hypertension | **Hypertension | ||
** | **[[Collagen vascular disease]] (e.g. [[SLE]], [[scleroderma]], [[rheumatoid arthritis]]) | ||
**Paraproteinemia (e.g. multiple myeloma) | **Paraproteinemia (e.g. [[multiple myeloma]]) | ||
**Recent use of nephrotoxic medication (eg, metformin, aminoglycosides) | **Recent use of nephrotoxic medication (eg, [[metformin]], [[aminoglycosides]]) | ||
==See Also== | ==See Also== | ||
Revisión del 14:49 14 oct 2019
Background
- It may be possible to reduce the use of creatinine screening in ED patients requiring IV contrast for CT or other radiographic evaluation
- Data is sparse, however, and any guidelines should be utilized with that in mind, and in the context of local policies.
Guideline
ED patients do NOT require creatinine measurement prior to IV contrast:
- If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment (e.g. trauma patients)
- If they do not meet any of the following criteria[1][2]:
- Age >60
- History of kidney disease
- Kidney transplant
- Dialysis
- Single kidney
- Renal cancer
- Kidney surgery
- Family history of kidney failure
- Diabetes
- Hypertension
- Collagen vascular disease (e.g. SLE, scleroderma, rheumatoid arthritis)
- Paraproteinemia (e.g. multiple myeloma)
- Recent use of nephrotoxic medication (eg, metformin, aminoglycosides)